Evaluation of hepatic iron concentration heterogeneities using the MRI R2* mapping method.


Journal

European journal of radiology
ISSN: 1872-7727
Titre abrégé: Eur J Radiol
Pays: Ireland
ID NLM: 8106411

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 25 10 2017
revised: 05 02 2018
accepted: 09 02 2018
entrez: 3 6 2019
pubmed: 4 6 2019
medline: 5 9 2019
Statut: ppublish

Résumé

To measure hepatic iron concentration (HIC) heterogeneities using a magnetic resonance R2* mapping method. Ninety-four patients with suspected hepatic iron overload and 10 volunteers were included prospectively. A multi-echo R2* sequence with fat saturation and with three post-processing fitting methods (a single exponential decay model with or without truncation, SED and SEDt, and a constant offset model, COS) was compared to a signal intensity ratio method (SIR), considered as the reference. HIC heterogeneity was evaluated from R2* mapping after placing a ROI on each liver segment. A strong linear correlation between SIR and R2* methods using the SEDt and COS models was observed (r = 0.973 and 0.955, respectively). Volunteers and patient liver variabilities, quantified by mean intra-liver standard deviation (SD) were 1.58 μmol/g (mean range 5.06 μmol/g) and 4.73 μmol/g (mean range 19.08 μmol/g), respectively. For the patient group, the highest HIC was observed in the IV This study is the first to demonstrate in vivo HIC heterogeneities using whole-liver mapping analysis. These preliminary results require confirmation through further studies, but might be useful in cases of single ROI analysis.

Identifiants

pubmed: 31153573
pii: S0720-048X(18)30049-4
doi: 10.1016/j.ejrad.2018.02.011
pii:
doi:

Substances chimiques

Iron E1UOL152H7

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

47-54

Informations de copyright

Copyright © 2018. Published by Elsevier B.V.

Auteurs

Jean Mazé (J)

Imaging Department, CHU de Poitiers, 2 Rue de la milétrie, 86000 CHU de Poitiers, France.

Guillaume Vesselle (G)

Imaging Department, CHU de Poitiers, 2 Rue de la milétrie, 86000 CHU de Poitiers, France.

Guillaume Herpe (G)

Imaging Department, CHU de Poitiers, 2 Rue de la milétrie, 86000 CHU de Poitiers, France.

Samy Boucebci (S)

Imaging Department, CHU de Poitiers, 2 Rue de la milétrie, 86000 CHU de Poitiers, France.

Christine Silvain (C)

Hepatology Department, CHU de Poitiers, 2 Rue de la milétrie, 86000 CHU de Poitiers, France.

Pierre Ingrand (P)

Inserm U619, CHU de Poitiers et University of Poitiers, Rue de la milétrie, 86000 CHU de Poitiers, France.

Jean-Pierre Tasu (JP)

Imaging Department, CHU de Poitiers, 2 Rue de la milétrie, 86000 CHU de Poitiers, France. Electronic address: jean-pierre.tasu@chu-poitiers.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH